Page 26 - Jourmal of World Association of Laparoscopic Surgeon
P. 26

Mohamed Solih

           18. van Pinxteren B, Numans ME, Bonis PA, et al. Short-term  28. Chadalavada R, Lin E, Sedghi S Smith. Comparative results of
              treatment with proton pump inhibitors, H2- receptor antagonists  endoluminal gastroplasty and laparoscopic antireflux surgery
              and prokinetics for gastroesophageal reflux disease-like  for the treatment of GERD. Surg Endosc 18(2):261-65.
              symptoms and endoscopy negative reflux disease. Cochrane  29. Chuttani R, Sud R, Sachdev G, et al. A novel endoscopic full-
              Database Syst Rev 2006;3:CD002095.                  thickness plicator for the treatment of GERD: A pilot study.
           19. Liakakos T, Karamanolis G, Patapis P, Misiakos E.  Gastrointest Endosc 58(5):452-512.
              Gatroeshophageal reflux disease: Medical or surgical treatment?  30. Hagedorn C, Lonroth H, Ruth M, Lundell L. Long-term efficacy
              Gastroenterol Res Prac 2009;10;1-15.                of total (Nissen Rossetti) and posterior partial (Toupet)
           20. Fass F. Proton pump inhibitor failure—what are the therapeutic  fundoplication: Results of a randomized clinical trial.
              options? Am J Gastroenterol 2009;104: S33-38.       J Gastrointest Surg 6(4):540-45.
           21. Lee ES, Lee S, et al. Comparison of risk factors and clinical  31. Hunter JG, Swanstrom L, Waring JP. Dysphagia after
              responses to proton pump inhibitors in patients with erosive  laparoscopic antireflux surgery: The impact of operative
              oesophagitis and nonerosive reflux disease. Aliment Pharmacol  technique. Annals Surg 1996;224(1):51-57.
              Ther 30(2):154-64.                              32. Lundell L, Miettinen P, Myrvold HE, et al. Seven years
           22. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical  follow-up of a randomized clinical trial comparing proton-pump
              treatments for the maintenance therapy of reflux esophagitis  inhibition with surgical therapy for reflux oesophagitis. Br J
              and endoscopic negative reflux disease. Cochrane Database Sys  Surg 2007;94(2):198-203.
              Rev 2010;2:CD003245.                            33. Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results
           23. Ali T, Roberts DN, et al. Long-term safety concerns with proton  of laparoscopic fundoplication at 10 years after surgery. Surg
              pump inhibitors. Am J of Med 2009;122:896-903.      Endosc 2006;20(1):159-65.
           24. Targownik LE, Lix LM, et al. Use of proton pump inhibitors  34. Zornig C, Strate U, Fibbe C, Emmermann A, Layer P. Nissen
              and risk of osteoporosis-related fratures. CMAJ 179(4):306-07.  vs Toupet laparoscopic fundoplication: A prospective
           25. Catarci M, Gentileschi P, et al. Evidence based appraisal of  randomized study of 200 patients with and without preoperative
                                                                  esophageal motility disorders. Surg Endosc 2002;16(5):758-66.
              antireflux fundoplication. Annals Surg 239(3):325-37.
           26. Lundell L, Attwood Ell C, et al. Comparing laparoscopic
              antireflux surgery with esomeprazole in the management of  ABOUT THE AUTHOR
              patients with chronic gastroesophageal reflux disease: A 3 years  Mohamed Solih
              interim analysis of the LOTUS trial. GUT 2008;57:1207-13.
           27. Dallemagne B. Laparoscopic fundoplication. Gastroesophageal  Department of Surgery, Indira Gandhi Memorial Hospital, Male
              Reflux Disease 2006;173-82.                     Republic of Maldives, e-mail: dr.mohamed.solih@gmail.com













































          28
   21   22   23   24   25   26   27   28   29   30   31